iRhythm Holdings, Inc. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
iRhythm Holdings, Inc. (IRTC) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $21.30 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-06
- iRhythm Holdings, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $21.30M, a 12.30% decline year-over-year.
- iRhythm Holdings, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $22.61M, a 8.65% decline year-over-year.
- iRhythm Holdings, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $22.31M, a 18.29% increase year-over-year.
- iRhythm Holdings, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $24.29M, a 1.20% increase year-over-year.
- iRhythm Holdings, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $93.54M, a 13.03% increase from fiscal 2024.
- iRhythm Holdings, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $82.76M, a 2.16% decline from fiscal 2023.
- iRhythm Holdings, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $84.59M, a 32.99% increase from fiscal 2022.
- iRhythm Holdings, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $63.60M, a 13.08% increase from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $21.30M 10-Q · filed 2026-08-06 | $43.91M derived: sum of 2 quarters · filed 2026-08-06 | |||
| 2026-03-31 | $22.61M 10-Q · filed 2026-08-06 | ||||
| 2025-12-31 | $93.54M 10-K · filed 2026-02-19 | ||||
| 2025-09-30 | $22.31M 10-Q · filed 2025-10-30 | $46.60M derived: sum of 2 quarters · filed 2026-08-06 | $71.35M derived: sum of 3 quarters · filed 2026-08-06 | ||
| 2025-06-30 | $24.29M 10-Q · filed 2026-08-06 | $49.04M derived: sum of 2 quarters · filed 2026-08-06 | |||
| 2025-03-31 | $24.75M 10-Q · filed 2026-08-06 | ||||
| 2024-12-31 | $82.76M 10-K · filed 2026-02-19 | ||||
| 2024-09-30 | $18.86M 10-Q · filed 2025-10-30 | $42.86M derived: sum of 2 quarters · filed 2025-10-30 | $65.50M derived: sum of 3 quarters · filed 2025-10-30 | ||
| 2024-06-30 | $24.00M 10-Q · filed 2025-10-30 | $46.64M derived: sum of 2 quarters · filed 2025-10-30 | |||
| 2024-03-31 | $22.64M 10-Q · filed 2025-10-30 | ||||
| 2023-12-31 | $84.59M 10-K · filed 2026-02-19 | ||||
| 2023-09-30 | $22.83M 10-Q · filed 2024-10-30 | $39.05M derived: sum of 2 quarters · filed 2024-10-30 | $58.95M derived: sum of 3 quarters · filed 2024-10-30 | $76.31M derived: sum of 4 quarters · filed 2025-02-20 | |
| 2023-06-30 | $16.23M 10-Q · filed 2024-10-30 | $36.13M derived: sum of 2 quarters · filed 2024-10-30 | $53.48M derived: sum of 3 quarters · filed 2025-02-20 | $67.95M derived: sum of 4 quarters · filed 2025-02-20 | |
| 2023-03-31 | $19.90M 10-Q · filed 2024-10-30 | $37.25M derived: sum of 2 quarters · filed 2025-02-20 | $51.72M derived: sum of 3 quarters · filed 2025-02-20 | $68.35M derived: sum of 4 quarters · filed 2025-02-20 | |
| 2022-12-31 | $17.35M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $31.82M derived: sum of 2 quarters · filed 2025-02-20 | $48.45M derived: sum of 3 quarters · filed 2025-02-20 | $63.60M 10-K · filed 2025-02-20 | |
| 2022-09-30 | $14.47M 10-Q · filed 2023-11-02 | $31.10M derived: sum of 2 quarters · filed 2023-11-02 | $46.25M 10-Q · filed 2022-11-04 | $59.19M derived: sum of 4 quarters · filed 2024-02-22 | |
| 2022-06-30 | $16.63M 10-Q · filed 2023-11-02 | $31.78M 10-Q · filed 2022-08-05 | $44.72M derived: sum of 3 quarters · filed 2024-02-22 | $57.78M derived: sum of 4 quarters · filed 2024-02-22 | |
| 2022-03-31 | $15.15M 10-Q · filed 2023-11-02 | $28.09M derived: sum of 2 quarters · filed 2024-02-22 | $41.15M derived: sum of 3 quarters · filed 2024-02-22 | $52.13M derived: sum of 4 quarters · filed 2024-02-22 | |
| 2021-12-31 | $12.94M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $26.00M derived: sum of 2 quarters · filed 2024-02-22 | $36.98M derived: sum of 3 quarters · filed 2024-02-22 | $56.25M 10-K · filed 2024-02-22 | |
| 2021-09-30 | $13.06M 10-Q · filed 2022-11-04 | $24.04M derived: sum of 2 quarters · filed 2022-11-04 | $43.31M 10-Q · filed 2022-11-04 | $54.83M derived: sum of 4 quarters · filed 2023-02-23 | |
| 2021-06-30 | $10.98M 10-Q · filed 2022-08-05 | $30.25M 10-Q · filed 2022-08-05 | $41.76M derived: sum of 3 quarters · filed 2023-02-23 | $56.36M derived: sum of 4 quarters · filed 2023-02-23 | |
| 2021-03-31 | $19.27M 10-Q · filed 2022-05-06 | $30.78M derived: sum of 2 quarters · filed 2023-02-23 | $45.38M derived: sum of 3 quarters · filed 2023-02-23 | $53.27M derived: sum of 4 quarters · filed 2023-02-23 | |
| 2020-12-31 | $11.52M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $26.12M derived: sum of 2 quarters · filed 2023-02-23 | $34.00M derived: sum of 3 quarters · filed 2023-02-23 | $34.30M 10-K · filed 2023-02-23 | |
| 2020-09-30 | $14.60M 10-Q · filed 2021-11-05 | $22.48M derived: sum of 2 quarters · filed 2021-11-05 | $22.79M 10-Q · filed 2021-11-05 | $29.97M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2020-06-30 | $7.88M 10-Q · filed 2021-08-09 | $8.19M 10-Q · filed 2021-08-09 | $15.37M derived: sum of 3 quarters · filed 2022-02-28 | $22.77M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2020-03-31 | $305.00K 10-Q · filed 2021-05-10 | $7.48M derived: sum of 2 quarters · filed 2022-02-28 | $14.88M derived: sum of 3 quarters · filed 2022-02-28 | $21.69M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2019-12-31 | $7.18M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $14.58M derived: sum of 2 quarters · filed 2022-02-28 | $21.39M derived: sum of 3 quarters · filed 2022-02-28 | $26.24M 10-K · filed 2022-02-28 | |
| 2019-09-30 | $7.40M 10-Q · filed 2020-11-06 | $14.21M derived: sum of 2 quarters · filed 2020-11-06 | $19.06M 10-Q · filed 2020-11-06 | ||
| 2019-06-30 | $6.81M 10-Q · filed 2020-08-07 | $11.66M 10-Q · filed 2020-08-07 | |||
| 2019-03-31 | $4.86M 10-Q · filed 2020-05-08 | ||||
| 2018-12-31 | $16.33M 10-K · filed 2021-02-26 | ||||
| 2018-09-30 | $4.21M 10-Q · filed 2019-12-23 | $8.29M derived: sum of 2 quarters · filed 2019-12-23 | $11.53M derived: sum of 3 quarters · filed 2019-12-23 | ||
| 2018-06-30 | $4.08M 10-Q · filed 2019-12-23 | $7.32M derived: sum of 2 quarters · filed 2019-12-23 | |||
| 2018-03-31 | $3.25M 10-Q · filed 2019-12-23 | ||||
| 2017-12-31 | $9.75M 10-K · filed 2020-03-02 | $10.12M 10-K · filed 2018-03-01 | |||
| 2016-12-31 | $1.87M 10-K · filed 2019-03-04 | ||||
| 2015-12-31 | $1.41M 10-K · filed 2018-03-01 | ||||
| 2014-12-31 | $828.00K 10-K · filed 2017-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |